Related Experiment Video
Updated: Jul 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lowering LDL cholesterol in adults: a prospective, community-based practice initiative
Gregg O Coodley1, Maryclair Jorgensen, Jack Kirschenbaum
1Fanno Creek Clinic, LLC, Portland, Ore, USA. coodley@fannocreek.com
Implementing clinic-wide lipid-lowering initiatives effectively reduced low-density lipoprotein cholesterol (LDL) levels in an outpatient setting. This strategy shows promise for improving long-term cardiovascular health in community-based populations.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Internal Medicine
Background:
- Elevated low-density lipoprotein cholesterol (LDL) is a significant risk factor for cardiovascular disease.
- Effective management strategies are crucial in community-based outpatient settings.
- The National Cholesterol Education Program/Third Adult Treatment Panel (NCEP/ATP III) guidelines provide targets for LDL cholesterol.
Purpose of the Study:
- To evaluate the effectiveness of a clinic-wide initiative using LDL-lowering interventions.
- To assess the strategy's impact on achieving target LDL levels (<100 mg/dL) in an internal medicine outpatient setting.
- To determine if this approach serves as a viable health maintenance strategy.
Main Methods:
- Screened 1375 patients for baseline LDL (LDL(1)).
- Patients with LDL(1) >100 mg/dL received a lipid-lowering action plan and follow-up LDL (LDL(2)) in 3-4 months.
- A second action plan and LDL(3) measurement were given to patients not meeting targets, with secondary endpoint analysis of total cholesterol, triglycerides, and HDL cholesterol.
Main Results:
- Of 514 patients on action plans, 443 returned; LDL(1) decreased from 140.7±29.2 to 110.9±29.6 mg/dL (P<.05).
- 167 patients achieved LDL <100 mg/dL, and 87 were controlled (100-130 mg/dL) after the first intervention.
- A second intervention for 158 patients resulted in LDL reduction from 139.9±24.4 to 112.5±28.2 mg/dL (P<.05) in 50 returning patients; HDL levels increased, and triglycerides/cholesterol decreased.
Conclusions:
- Community-based physicians can significantly reduce patient LDL cholesterol through structured lipid-lowering initiatives.
- Close monitoring and implementation of these initiatives can lead to substantial improvements in patient lipid profiles.
- This approach offers a potentially large positive impact on the long-term health and well-being of patients.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...